145 related articles for article (PubMed ID: 19481116)
1. A new strategy for constructing in vitro replication-competent 1.3 copies of hepatitis B virus genome.
Hu JL; Cui J; Deng XY; Zhang WL; Li QL; Guo JJ; Zeng AZ; Huang AL
J Virol Methods; 2009 Oct; 161(1):63-9. PubMed ID: 19481116
[TBL] [Abstract][Full Text] [Related]
2. Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus.
Sun D; Nassal M
J Hepatol; 2006 Nov; 45(5):636-45. PubMed ID: 16935386
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
Ren S; Nassal M
J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
[TBL] [Abstract][Full Text] [Related]
4. [Study on the replication of hepatitis B virus compared with that of duck hepatitis B virus in primary duck hepatocytes].
Yao Y; Tang N; Huang A
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1157-61. PubMed ID: 11769700
[TBL] [Abstract][Full Text] [Related]
5. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs.
Weiss L; Kekulè AS; Jakubowski U; Bürgelt E; Hofschneider PH
Virology; 1996 Feb; 216(1):214-8. PubMed ID: 8614990
[TBL] [Abstract][Full Text] [Related]
6. High level virion production and surface antigen expression with 1.5 copies of hepatitis B viral genome.
Dong Q; Liu Z; Chen Y; Chan CY; Lin MC; Kung HF; Chan HL; Sung JJ; He ML
J Virol Methods; 2009 Aug; 159(2):135-40. PubMed ID: 19490966
[TBL] [Abstract][Full Text] [Related]
7. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
Ma ZM; Lin X; Wang YX; Tian XC; Xie YH; Wen YM
J Med Virol; 2009 Feb; 81(2):230-7. PubMed ID: 19107969
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
[TBL] [Abstract][Full Text] [Related]
9. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns.
Pan XB; Wei L; Chen HS; Liu F; Gao Y
Arch Virol; 2007; 152(6):1159-73. PubMed ID: 17308979
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
11. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis.
Zhang J; Niu D; Sui J; Ching CB; Chen WN
Proteomics; 2009 May; 9(10):2836-45. PubMed ID: 19405029
[TBL] [Abstract][Full Text] [Related]
12. [On the role of liver-enriched transcription factors in regulating HBV transcription and replication].
Wang S; Tang H; He F; Liu L; Huang FJ; Zhou TY; Zhao LS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):35-9. PubMed ID: 16468637
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
[TBL] [Abstract][Full Text] [Related]
14. A putative new domain target for anti-hepatitis B virus: residues flanking hepatitis B virus reverse transcriptase residue 306 (rtP306).
Wang YX; Xu X; Luo C; Ma ZM; Jiang HL; Ding JP; Wen YM
J Med Virol; 2007 Jun; 79(6):676-82. PubMed ID: 17457904
[TBL] [Abstract][Full Text] [Related]
15. [Construction of recombinant replication competent plasmids containing HBV genome with mutations of precore and basic core promoter].
Wang Y; Jiang D; Wei L; Chen HS; Cong X; Fei R; Wang Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):218-22. PubMed ID: 15640852
[TBL] [Abstract][Full Text] [Related]
16. [Replication and encapsidation of HBV mutants with the truncated C gene].
Han JQ; Hu DR; Xiong JH; Hu XL; Fan GR; Li J; Liu CY; Di YP; Wu YP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):39-42. PubMed ID: 15340524
[TBL] [Abstract][Full Text] [Related]
17. Microfluidic platform for hepatitis B viral replication study.
Sodunke TR; Bouchard MJ; Noh HM
Biomed Microdevices; 2008 Jun; 10(3):393-402. PubMed ID: 18165913
[TBL] [Abstract][Full Text] [Related]
18. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis B virus (HBV) by LNA-mediated nuclear interference with HBV DNA transcription.
Sun Z; Xiang W; Guo Y; Chen Z; Liu W; Lu D
Biochem Biophys Res Commun; 2011 Jun; 409(3):430-5. PubMed ID: 21596023
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
